Joel Z. Stengel
Brooke Army Medical Center · 11 works · 2,346 citations · h-index 5
Top works
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- Is infliximab safe to use while breastfeeding?
- MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies
- Single-Dose Lubiprostone Along With Split-Dose PEG Solution Without Dietary Restrictions for Bowel Cleansing Prior to Colonoscopy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.
- Infliximab: A Review of its Use in the Treatment of Crohn's Disease
- med-7. Cushingʼs Syndrome: A Diagnostic Dilemma.
- A Randomized Blinded Prospective Trial Comparing PEG 3350 (MiraLAX®) with Bisacodyl Pretreatment versus PEG 3350 (MiraLAX®) with Lubiprostone Pretreatment versus PEG 3350 (MiraLAX®) without Pretreatment versus PEG 3350 (Golytely®) for Bowel Cleansing Prior to Colonoscopy: 2010 Presidential Poster
- Contributors
- Endoscopic Cancer Screening and Surveillance